ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
4,982.77
-1.57%
US Tech 100
16,751.20
0.65%
다우존스 지수
37,645.59
-0.84%
Bitcoin
77,282.65
1.32%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Monte Rosa Therapeutics Inc (GLUE) 시세

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc (GLUE)

NASDAQ
3.92
-0.14
(-3.33%)
마감 09 4월 5:00AM
15분 지연
3.92
0.00
( 0.00% )
시간외 단일가: 5:40PM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
3.92
매수가
3.80
매도가
4.95
거래량
24
0.00 일간 변동폭 0.00
3.21 52주 범위 12.40
market_cap
241.118M
전일 종가
3.92
개장가
-
최근 거래 시간
1
@
3.51
마지막 거래 시간
17:40:34
재정 규모
-
VWAP
-
평균 볼륨(3m)
687,320
발행 주식
61,509,821
배당수익률
-
주가수익률
-3.32
주당순이익(EPS)
-1.18
매출
75.62M
순이익
-72.7M

Monte Rosa Therapeutics Inc 정보

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
www.monterosatx.com.
본부
Wilmington, Delaware, USA
설립됨
-
Monte Rosa Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker GLUE. The last closing price for Monte Rosa Therapeutics was US$3.92. Over the last year, Monte Rosa Therapeutics shares have traded in a share price range of US$ 3.21 to US$ 12.40.

Monte Rosa Therapeutics currently has 61,509,821 shares in issue. The market capitalisation of Monte Rosa Therapeutics is US$241.12 million. Monte Rosa Therapeutics has a price to earnings ratio (PE ratio) of -3.32.

GLUE 최신 뉴스

추가 뉴스

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
01 4월 2025
GLUE (-3.33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
26 3월 2025
GLUE (-3.33%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
20 3월 2025
GLUE (-3.33%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
20 3월 2025
GLUE (-3.33%)

Form 8-K - Current report
Edgar (US Regulatory)
20 3월 2025
GLUE (-3.33%)

Form 8-K - Current report
Edgar (US Regulatory)
10 1월 2025
GLUE (-3.33%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.41-9.46882217094.334.67173.50018778264.01251948CS
4-2.33-37.286.257.313.50018681765.51982353CS
12-2.11-34.9917081266.037.313.50016873205.83950029CS
26-1.07-21.44288577154.9912.43.500117068758.35264146CS
52-3.63-48.07947019877.5512.43.219863417.86278604CS
156-8.79-69.158143194312.7114.192.444571787.55892719CS
260-18.08-82.18181818182245.562.444136439.17563654CS

GLUE - Frequently Asked Questions (FAQ)

What is the current Monte Rosa Therapeutics share price?
The current share price of Monte Rosa Therapeutics is US$ 3.92
How many Monte Rosa Therapeutics shares are in issue?
Monte Rosa Therapeutics has 61,509,821 shares in issue
What is the market cap of Monte Rosa Therapeutics?
The market capitalisation of Monte Rosa Therapeutics is USD 241.12M
What is the 1 year trading range for Monte Rosa Therapeutics share price?
Monte Rosa Therapeutics has traded in the range of US$ 3.21 to US$ 12.40 during the past year
What is the PE ratio of Monte Rosa Therapeutics?
The price to earnings ratio of Monte Rosa Therapeutics is -3.32
What is the cash to sales ratio of Monte Rosa Therapeutics?
The cash to sales ratio of Monte Rosa Therapeutics is 3.19
What is the reporting currency for Monte Rosa Therapeutics?
Monte Rosa Therapeutics reports financial results in USD
What is the latest annual turnover for Monte Rosa Therapeutics?
The latest annual turnover of Monte Rosa Therapeutics is USD 75.62M
What is the latest annual profit for Monte Rosa Therapeutics?
The latest annual profit of Monte Rosa Therapeutics is USD -72.7M
What is the registered address of Monte Rosa Therapeutics?
The registered address for Monte Rosa Therapeutics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Monte Rosa Therapeutics website address?
The website address for Monte Rosa Therapeutics is www.monterosatx.com.
Which industry sector does Monte Rosa Therapeutics operate in?
Monte Rosa Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
VEROVenus Concept Inc
US$ 8.37
(186.64%)
1.92M
FMTOFemto Technologies Inc
US$ 5.84
(107.83%)
3.72M
WORXSCWorx Corporation
US$ 1.36
(70.85%)
10.7M
ELTXElicio Therapeutics Inc
US$ 8.29
(59.73%)
47
FLLFull House Resorts Inc
US$ 5.01
(59.55%)
31
OSTOstin Technology Group Company Ltd
US$ 0.46
(-59.60%)
27.05k
GCMGGCM Grosvenor Inc
US$ 5.34
(-55.90%)
3
PESIPermaFix Environmental Services Inc
US$ 3.00
(-53.92%)
202
VINCVincerx Inc
US$ 0.2585
(-52.39%)
55.39k
BLFSBioLife Solutions Inc
US$ 10.01
(-51.50%)
14
BTOGBit Origin Ltd
US$ 0.1767
(19.31%)
13.7M
WORXSCWorx Corporation
US$ 1.36
(70.85%)
10.7M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.25
(6.77%)
9.75M
SUNESUNation Energy Inc
US$ 0.0274
(-9.57%)
9.45M
DMNDamon Inc
US$ 0.0117
(-5.65%)
6.13M

GLUE Discussion

게시물 보기
Monksdream Monksdream 4 월 전
GLUE, under $7

👍️0
corncakes0 corncakes0 5 월 전
Hmm
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE investors have been in what Cramer calls "the house of pain" for months. Many purchased this at $40,$50,$60,$70 per share. The company will be added to the long list of biotech failures once the inevitable FDA trial failure is confirmed.
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE will soon be added to this list

https://www.fiercebiotech.com/special-reports/2023s-top-10-clinical-trial-flops

👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE trapped alot of "investors" earlier this week at 10+ all the way to 12.50/Share. It is cratering just as precipitously. Watch for less than 8....7.....6... in days to come.
👍️0
Woodpecker3 Woodpecker3 5 월 전
$GLUE - No products. no revenues, massive losses, running out of cash. Millions of shares avaiable to short. Looking for $5/share
👍️0
Monksdream Monksdream 7 월 전
GLUE under $7
👍️0
Monksdream Monksdream 7 월 전
GLUE under $6
👍️0
Monksdream Monksdream 8 월 전
GLUE under $5
👍️0
Monksdream Monksdream 9 월 전
GLUE under $5
👍️0

최근 히스토리

NASDAQ
GLUE
Monte Rosa Therapeutics
COIN
ANKRUST
Ankr Network
NYSE
UE
Urban Edge Properties
NASDAQ
ELGX
Endologix
LBNK
ATCBTC
ASTOSCH COIN
Delayed Upgrade Clock
ADVFN Logo
대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지